Arrowhead Pharmaceuticals, Inc. (LON:0HI3)
London · Delayed Price · Currency is GBP · Price in USD 68.38
+7.40 (12.14%)
Dec 8, 2025, 3:17 PM BST
Arrowhead Pharmaceuticals Market Cap
Arrowhead Pharmaceuticals has a market cap or net worth of 6.26 billion as of December 8, 2025. Its market cap has increased by 243.28% in one year.
Market Cap
6.26B
Enterprise Value
6.15B
Revenue
617.06M
Ranking
n/a
PE Ratio
n/a
Stock Price
68.38
Market Cap Chart
Since January 13, 2004, Arrowhead Pharmaceuticals's market cap has increased from 17.94M to 6.26B, an increase of 34,800.81%. That is a compound annual growth rate of 30.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 6.26B | 235.16% |
| Dec 31, 2024 | 1.87B | -27.60% |
| Dec 29, 2023 | 2.58B | -27.67% |
| Dec 30, 2022 | 3.57B | -30.28% |
| Dec 31, 2021 | 5.12B | -11.38% |
| Dec 31, 2020 | 5.77B | 20.21% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| GSK plc | 72.47B |
| Haleon | 32.12B |
| Smith & Nephew | 10.72B |
| Convatec Group | 4.47B |
| Hikma Pharmaceuticals | 3.53B |
| HUTCHMED (China) | 1.83B |
| Genus | 1.73B |